Clinical trials located in

Móstoles

Móstoles city is located in Spain. Currently, 7 clinical trials are being conducted in this city.

Móstoles, a city in Spain, is renowned for its historical significance in the Spanish War of Independence against Napoleon’s forces, marked by the May 2, 1808, uprising. This event is commemorated annually, showcasing the city’s rich cultural heritage. Móstoles has evolved into a vibrant urban center, blending modern amenities with green spaces like Parque Natural El Soto. It’s also home to the Universidad Rey Juan Carlos, contributing to its dynamic educational landscape. The city’s commitment to arts is evident in its numerous cultural institutions and events.

  • CT-EU-00057388

    Dose-finding study on Daridorexant for pediatric insomnia

    This study aims to figure out the right amount of daridorexant to give to children aged 10 to less than 18 who struggle with sleep. Researchers will be testing various doses of the medication to see how well it works and whether it’s safe for these kids. The goal is to find the most effective and suitable dose that can help improve their sleep without causing any harm.

    • Daridorexant
  • Comparison of different treatments for follicular lymphoma

    This study involves comparing two treatments for a condition known as follicular or marginal zone lymphoma, both of which are types of cancer affecting lymph cells. The first treatment combines zanubrutinib with an antibody called Anti-CD20, while the second treatment involves lenalidomide and rituximab. These treatments are intended for patients who have not responded or have stopped responding to conventional treatment. One of the primary objectives of the study is to determine which treatment is more effective in preventing the cancer from progressing, referred to as progression-free survival. Additionally, the study aims to assess the impact of these treatments on the patients’ quality of life, evaluating various aspects through questionnaires related to physical and emotional well-being, symptoms, and the ability to perform normal activities.

    • Zanubrutinib
    • Obinutuzumab
    • Lenalidomide
    • Rituximab
  • Study on dazostinag & pembrolizumab for advanced solid tumors

    The purpose of this study is to test a new drug called dazostinag. A study is being conducted to see whether this drug is helpful in adults with advanced forms of solid cancer. Some people are given dazostinag alone, while others are given it with another medicine called pembrolizumab. Scientists’ focus here is on finding out whether these drugs cause any side effects, and finding out what the maximum dose is that people can take without serious side effects. The study consists of two parts, including a dose escalation phase and a dose escalation phase. In the first part, the dose of dazostinag will be gradually increased, given alone or in combination with pembrolizumab. In the second part, Dazostinag will be tested with pembrolizumab and other anticancer drugs. This section will focus on patients with specific cancers that are difficult to remove or have spread to other parts of the body.

    • Dazostinag
    • Platinum
    • Pembrolizumab
    • 5-Fluorouracil
  • CT-EU-00038763

    Assessing Levonorgestrel Vaginal Delivery System (LVDS) as a new birth control system

    This clinical trial tests LVDS, a new vaginal contraceptive method, in women aged 15 to 45. It’s a phase 3 study to determine the contraceptive’s effectiveness, safety, and tolerability over 13 cycles. The trial includes various assessments such as pregnancy tests, gynecological exams, and quality of life questionnaires. Participants will use an e-diary app to record usage and vaginal bleeding. This research aims to offer a new contraceptive option that is convenient and effective for women.

    • levonorgestrel
  • Comparatively studying drug combinations for multiple myeloma treatment

    This study is testing different combinations of drugs used to treat a cancer called multiple myeloma. Patients will receive one of two sets of treatments. One set contains a medicine called belantamab mafodotin combined with two others, while the second set contains the same two medicines but with another third medicine called bortezomib. The main goal is to determine which of these combinations is more effective in patients with multiple myeloma, especially those for whom other treatments have failed. Researchers will measure how many participants see the disease go away, how long the disease is kept in check, and overall survival rates. In addition, they will use questionnaires to assess your quality of life and understand the range of symptoms or problems you may experience during the examination.

    • Belantamab mafodotin
    • Pomalidomide
    • Dexamethasone
    • Bortezomib
  • Study of new drugs in acute lymphoblastic leukemia

    This clinical trial focuses on improving treatment strategies for acute lymphoblastic leukemia (ALL) in a diverse age group, from infants to young adults up to 45 years old. The study combines standard treatments with new drugs, for example, Inotuzumab Ozogamicin and Blinatumomab. The trial aims to tailor treatment to individual patient needs and reduce toxicity while maintaining treatment quality. By carefully monitoring event- and disease-free survival rates, as well as minimal residual disease responses, the trial aims to improve the standard of care for ALL and improve both survival outcomes and patient quality of life.

    • Inotuzumab Ozogamicin
    • 6-tioguanine
    • Blinatumomab
    • Imatinib
    • Dexamethasone
    • Vincristine
    • Doxorubicin
  • Exploring sacituzumab govitecan for HER2-negative breast cancer care

    This study is evaluating a new treatment for patients with a certain type of breast cancer (HER2-negative) who have not had a complete response to initial chemotherapy. Participants are randomly assigned to receive the investigational drug sacituzumab govitecan or a treatment of their physician’s choice, which may be another type of chemotherapy with capecitabinalub, carboplatin or cisplatin. The study is designed to compare the effectiveness of these approaches in preventing cancer recurrence. Patients may also receive hormone therapy if needed. Patients’ safety and response to treatment are being closely monitored throughout the study.

    • Sacituzumab govitecan
    • Carboplatin
    • Cisplatin
    • Capecitabine

See more clinical trials in other cities in Spain:

.